Y-mAbs Therapeutics, Inc.

The current price of YMAB is 15.20 USD — it has increased by 1.95% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Y-mAbs Therapeutics, Inc. stocks are traded under the ticker YMAB.

Y-mAbs Therapeutics, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Y-mAbs Therapeutics, Inc. has a max estimate of 26.00 USD and a min estimate of 12.00 USD.

YMAB earnings for the last quarter are −0.18 USD whereas the estimation was −0.19 USD which accounts for 4.15% surprise. Estimated earnings for the next quarter are −0.20 USD. See more details about Y-mAbs Therapeutics, Inc. earnings.

Yes, you can track Y-mAbs Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, YMAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Y-mAbs Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

YMAB reached its all-time high on Nov 9, 2020 with the price of 55.22 USD, and its all-time low was 2.70 USD and was reached on Mar 24, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 100.00 employees. See our rating of the largest employees — is Y-mAbs Therapeutics, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Y-mAbs Therapeutics, Inc. EBITDA is ‪−24.94 M‬ USD, and current EBITDA margin is −24.12%. See more stats in Y-mAbs Therapeutics, Inc. financial statements.